Login / Signup

New-user and prevalent-user designs and the definition of study time origin in pharmacoepidemiology: A review of reporting practices.

Kim LuijkenJudith J SpekreijseMaarten van SmedenHelga GardarsdottirRolf H H Groenwold
Published in: Pharmacoepidemiology and drug safety (2021)
Almost half of the included studies reported implementing a new-user design. Implications of misalignment of study design origin were difficult to assess because it would require explicit reporting of the target estimand in original studies. We recommend that the choice for a particular study time origin is explicitly motivated to enable assessment of validity of the study.
Keyphrases
  • primary care
  • adverse drug
  • decision making